The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

Tumor infiltrating lymphocytes have been associated with a better prognostic and with higher response rates in patients treated with checkpoint inhibiting antibodies, suggesting that strategies promoting tumor inflammation may enhance the efficacy of these currently available therapies. Our aim was...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncoimmunology
Κύριοι συγγραφείς: Villanueva, Lorea, Silva, Leyre, Llopiz, Diana, Ruiz, Marta, Iglesias, Tamara, Lozano, Teresa, Casares, Noelia, Hervas-Stubbs, Sandra, Rodríguez, María José, Carrascosa, José L., Lasarte, Juan José, Sarobe, Pablo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Taylor & Francis 2017
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889285/
https://ncbi.nlm.nih.gov/pubmed/29632721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1409321
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια